In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance.
Antiviral Res
; 120: 112-21, 2015 Aug.
Article
en En
| MEDLINE
| ID: mdl-26036224
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Antivirales
/
Purinas
/
Piridazinas
/
Hepacivirus
/
Farmacorresistencia Viral
/
Sinergismo Farmacológico
Límite:
Humans
Idioma:
En
Año:
2015
Tipo del documento:
Article